Search for: "Takeda Pharmaceuticals" Results 1 - 20 of 451
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Feb 2021, 9:09 pm by Patent Docs
Noonan -- In a terse, non-precedential opinion, the Federal Circuit affirmed a district court's judgment that Defendants Torrent Pharmaceuticals and Indoco Remedies Ltd. had failed to prove that the claims asserted by Plaintiff/patentee Takeda were obvious, either under the statute or the judicially created doctrine of obviousness-type double patenting, in Takeda Pharmaceutical Co. v. [read post]
18 Aug 2015, 7:56 am by Law Offices of Jeffrey S. Glassman
Takeda Pharmaceuticals: Actos Litigation appeared first on Product Liability Lawyer Blog. [read post]
10 Apr 2015, 11:33 am by Pete Strom
Takeda Pharmaceuticals Offers to Settle Remaining Actos Injury Lawsuits for $2.2 Billion Japanese drug maker Takeda Pharmaceuticals announced that it has offered a settlement of $2.2 billion to end the remaining 8,000 lawsuits involving Actos injuries in the US. [read post]
3 Oct 2014, 10:38 am by Pete Strom
Takeda Claims Patient’s Smoking Led to Bladder Cancer, Not Actos Prescription The latest bellwether trial against Takeda Pharmaceuticals for injuries related to their Type 2 diabetes medication, Actos, began recently, and on Monday, September 29th, the pharmaceutical company claimed that the plaintiff’s bladder cancer was not caused by her Actos prescription, but by her age […] [read post]
27 May 2014, 7:58 am by Pete Strom
Actos Injury Case in Illinois Decided in Favor of Takeda Pharmaceuticals Takeda Pharmaceuticals, the drug company behind Type 2 diabetes drug Actos, won their most recent personal injury lawsuit that alleged that Actos caused the plaintiff’s bladder cancer. [read post]
13 May 2011, 1:08 am by By CHRIS V. NICHOLSON
Takeda Pharmaceuticals of Japan denied striking a deal for an acquisition after it emerged that the company was in talks to buy a Swiss rival, Nycomed, for up to $14 billion. [read post]
21 Feb 2006, 10:13 pm
District Court for the Southern District of New York Judge Denise Cote ruled yesterday that a patent owned by Takeda Pharmaceutical Co. [read post]
14 Apr 2014, 7:52 am by Pete Strom
Jury Says Takeda and Eli Lilly Must Pay $9 Billion for Actos Bladder Cancer Japanese pharmaceutical manufacturer Takeda Pharmaceutical and their US distributor Eli Lilly have been ordered to pay $9 billion in punitive damages after a federal court ruled that the companies hid potential cancer risks associated with taking Actos to treat Type 2 diabetes. [read post]
4 Aug 2014, 11:57 am by Dr. Shezad Malik
After a record breaking pharmaceutical $9 billion jury verdict involving Actos bladder cancer lawsuit, Takeda Pharmaceuticals and Eli Lilly, Actos manufacturers, have filed for a new trial. [read post]
19 May 2011, 4:21 am by By DEALBOOK
Takeda Pharmaceutical, the Japanese drug maker, agreed to buy Nycomed of Switzerland for 9.6 billion euros on Thursday, bolstering its presence in Europe and emerging markets. [read post]
19 May 2011, 4:21 am by By DEALBOOK
Takeda Pharmaceutical, the Japanese drug maker, agreed to buy Nycomed of Switzerland for 9.6 billion euros on Thursday, bolstering its presence in Europe and emerging markets. [read post]
20 Nov 2015, 7:56 am by Matthew L.M. Fletcher
Here: Takeda Opening Brief Connelly Answer Brief Takeda Reply Brief Lower court materials here. [read post]
19 May 2011, 1:18 pm by Brian Baxter
Edwards Angell Palmer & Dodge, CMS Cameron McKenna, Freshfields Bruckhaus Deringer, and White & Case are working on Japanese drugmaker Takeda Pharmaceutical's takeover of Swiss rival Nycomed. [read post]
21 Nov 2014, 7:58 am by Pete Strom
Jury Rules Takeda Must Pay for Lost Actos Files A jury ruled that Takeda Pharmaceuticals must pay $155,000 for its destruction or loss of files related to safety studies and information for their blockbuster Type 2 diabetes drug, Actos. [read post]
15 Mar 2010, 6:39 am by Varun Chhonkar
Diachii-owned Ranbaxy has lately entered into a settlement agreement with the Japanese drug manufacturer Takeda Pharmaceuticals to end patent lawsuit for anti-diabetic drug Actos, generically known as Pioglitazone Hydrochloride. [read post]
6 Oct 2014, 7:59 am by Pete Strom
Takeda Argues It Submitted All Relevant Actos Safety Studies, but Plaintiff Claims Company Sacrificed Safety for Profit Plaintiff Frances Wisniewski filed a personal injury lawsuit against Takeda Pharmaceuticals in 2012 in Philadelphia County Court of Common Pleas. [read post]
10 Feb 2014, 7:14 am by Pete Strom
Plaintiff Claims Takeda Knew About Bladder Cancer Risk from Actos, Hid Information As the first bellwether trial in the Actos multidistrict lawsuit (MDL) begins, the plaintiff’s attorney claims that Takeda Pharmaceuticals, manufacturers of Type 2 diabetes drug Actos, intentionally withheld information linking their blockbuster drug to bladder cancer. [read post]
9 Apr 2014, 11:20 am by tortsprof
On Monday, a jury in Louisiana ordered Eli Lilly and Takeda, a Japanese pharmaceutical company, to pay $1.475M in compensatory damages and $9B in punies for concealing cancer risks in the diabetes drug Actos. [read post]
3 Dec 2014, 11:24 am by Robert Kreisman
A U.S. district court judge has rejected the attempts of Takeda Pharmaceutical Co. and Eli Lilly & Co. to overturn the combined $9 billion punitive-damage award that a jury recently returned. [read post]